Onkology Kombine Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 26-04-2024
- Paid Up Capital ₹ 0.10 M
as on 26-04-2024
- Company Age 15 Year, 4 Months
- Last Filing with ROC 31 Mar 2022
- Revenue %
(FY 2021)
- Ebitda
- Net Worth
- Total Assets 0.09%
(FY 2021)
About Onkology Kombine
- CIN/LLPIN
U24100MH2009PTC194712
- Company No.
194712
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Aug 2009
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Onkology Kombine?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yogesh Navnitlal  | Director | 06-Aug-2009 | Current |
| Mehul Jayant | Director | 06-Aug-2009 | Current |
Financial Performance and Corporate Structure Insights of Onkology Kombine.
Onkology Kombine Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Onkology Kombine?
In 2021, Onkology Kombine had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Onkology Kombine?
Unlock and access historical data on people associated with Onkology Kombine, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Onkology Kombine, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Onkology Kombine's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
